Aug 4, 2025
Conditions such as vitreous floaters, age-related macular degeneration (AMD), diabetic retinopathy, and vitreomacular traction affect hundreds of millions of people worldwide.

52% of adults have floaters, where 5-10% of those impacted experience severe impairments and have no safe and non-invasive treatment options.
-
Vision Impairments
-
Anxiety
-
Stress
-
Depression
-
Reduced Quality of Life
Mild, moderate, and severe impairments from floaters.
There is a significant unmet need for a safe, effective and non-invasive office-based device to screen, diagnose, and treat eye floaters.

Latest developments, investments, and breakthroughs in our journey
Aug 4, 2025
We’re excited to introduce new team members helping shape the future of ophthalmology with bold ideas, technical excellence, and a shared commitment to impact.




